T cells and macrophages entered the injured kidney by 2-5 days; the associated upregulation of MHC class II antigen expression suggested increased immunogenicity of the organ. collected directly from the heart for determination of serum TNF-a, IL-6, urea and Creatinine. Both kidney were excised, the right one homogenized for oxidative stress parameters (MDA and GSH) measurements and the left kidney fixed in formalin for histological examination. == Results == Serum TNF-, IL-6, urea and Creatinine, kidney MDA levels and scores of histopathological changes were significantly (P < 0.05) elevated in I/R group as compared with that of sham group. Kidney GSH level was significantly (P < 0.05) decreased in I/R group as compared with that of sham group. MK-886 treated group has significantly (P NB001 < 0.05) lowered levels of all study parameters except for GSH level which was significantly (P < 0.05) higher as compared with that of I/R group. DITPA caused non-significant (P > 0.05) changes in levels of all study parameters as compared with that of I/R group. == Conclusion == The results of the present study show that MK-886 significantly ameliorated kidney damage that resulted from I/R. For DITPA, as its administration might not be successful, administration using a different protocol may give different effects on I/R. == Background == Acute kidney injury (AKI) is a common clinical syndrome characterized by rapid deterioration of renal function. AKI can be classified into NB001 three categories, namely, prerenal, intrinsic, and postrenal acute kidney injury. Progressive AKI leads to acute renal failure (ARF)[1]. ARF is an important clinical problem with a high mortality and morbidity. It affects 5% of hospitalized patients and has a mortality rate of approximately 50%[1]. One of the primary causes of ARF CACNLG is I/R which is a drop in blood flow leading to inadequate supply of oxygen and nutrients to renal tissue which can be caused by, amongst others, surgery, organ transplantation and shock [1]. In injury due to ischemia, neutrophil stimulation with accompanying oxygen radical-mediated injury is the main event that leads to injury; under ischemic conditions, reduced oxygen supply leads to enhanced neutrophil adherence to tubular endothelial cells [2-4] due to increased surface expression of adhesion molecules on tubular endothelial cells [2,4,5]. This ultimately results, on reperfusion, in diapedesis of neutrophils and their oxidative burst, which results in oxygen radical production [6,7]. So in addition to the direct cytotoxic effects of hypoxia, renal I/R induces an inflammatory reaction within the renal parenchyma [8] by causing renal synthesis of pro-inflammatory cytokines such as Interleukin (IL)-1, IL-6, IL-18, and tumor necrosis factor (TNF)-[9-12]. Many of the reactive oxygen species (ROS) produced by I/R activate the signaling mechanisms that culminate in TNF- production [13]. TNF- is a proinflammatory cytokine capable of up regulating its own expression, as well as the expression of other genes important in the inflammatory response [14]. TNF- and I/R increase iNOS activity to synthesize nitric oxide [15,16]. Nitric oxide production (by iNOS) may NB001 play several roles in renal pathophysiology, including induction of tubular damage. Prevention or reduction of nitric oxide generation reduces nitric oxide-induced renal injury [17], and the increased generation of nitric oxide is capable of inducing intracellular oxidizing reaction and cell death [18]. I/R injury of the kidney is characterized by a series of events, including changes in vascular tone, enhanced vascular permeability to plasma proteins, structural alterations in renal tubule and accumulation of activated neutrophils [19]. The cysteinyl LT, LTC4, LTD4, and LTE4, affect the tonus of the arterioles and the permeability of postcapillary venules, thereby causing endothelial contraction and macromolecular leakage [20]. LTB4is a mediator in the pathophysiology of the renal dysfunction caused by I/R of the kidney as well as the associated infiltration of the kidney with PMNs [21]. LTB4activates PMNs, thus changing their shape and promoting their binding to endothelium by inducing the expression of cell-adhesion molecules. After PMN transmigration into ischemic renal tissue, PMNs release reactive oxygen species, proteases, elastase, myeloperoxidase (MPO), cytokines, and various other mediators [19], all of which exacerbate inflammation and contribute to tissue injury (positive feedback). For instance, ROS will react with the polyunsaturated membrane lipids [22], and lipid peroxidation, in turn, will enhance the tissue levels of free arachidonic acid [23]. A potent and selective inhibitor of 5-lipoxygenase activating protein (FLAP) is MK-886[24]which binds to FLAP with high affinity and prevents the activation of 5-lipoxygenase. MK886.